Solimena, Michele
7 papers on CoChatORCID 0000-0002-3653-8107
Most cited papers
- Verified
Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase
Baekkeskov, S., Aanstoot, H.-J., Christgai, S., Reetz, A., Solimena, M., Cascalho, M., Folli, F., Richter-Olesen, H., & Camilli, P.-D. (1990) · Nature
Diabetes and associated disordersAutoimmune Neurological Disorders and Treatments
Cited by 1,964
- Verified
The insulin secretory granule as a signaling hub
Suckale, J., & Solimena, M. (2010) · Trends in Endocrinology & Metabolism
Pancreatic function and diabetesCellular transport and secretion
Cited by 201
- Verified
Biogenesis of secretory granules
Borgonovo, B., Ouwendijk, J., & Solimena, M. (2006) · Current Opinion in Cell Biology
Cellular transport and secretionPancreatic function and diabetes
Cited by 100
- Verified
Mechanisms of weight loss-induced remission in people with prediabetes: a post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS)
Sandforth, A., von Schwartzenberg, R. J., Arreola, E. V., Hanson, R. L., Sancar, G., Katzenstein, S., Lange, K., Preißl, H., Dreher, S. I., Weigert, C., et al. (2023) · The Lancet Diabetes & Endocrinology
Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management
Cited by 100
- Verified
PTBP1 Is Required for Embryonic Development before Gastrulation
Suckale, J., Wendling, O., Masjkur, J., Jäger, M., Münster, C., Anastassiadis, K., Stewart, A. F., & Solimena, M. (2011) · PLoS ONE
Developmental Biology and Gene RegulationRNA Research and Splicing
Cited by 55
- Verified
ICA69 is a novel Rab2 effector regulating ER-Golgi trafficking in insulinoma cells
Buffa, L., Fuchs, E., Pietropaolo, M., Barr, F., & Solimena, M. (2008) · European Journal of Cell Biology
Cellular transport and secretionPancreatic function and diabetes
Cited by 53
- Verified
Minimum effective low dose of antithymocyte globulin in people aged 5–25 years with recent-onset stage 3 type 1 diabetes (MELD-ATG): a phase 2, multicentre, double-blind, randomised, placebo-controlled, adaptive dose-ranging trial
Mathieu, C., Wych, J., Hendriks, A. E. J., Van Ryckeghem, L., Tree, T., Chmura, P., Möller, C., Casteels, K., Danne, T., Reschke, F., et al. (2025) · The Lancet
Diabetes and associated disordersDiabetes Management and Research
Cited by 17
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free